The MEB's Veterinary Medicinal Products Unit (VMPU) handles and assesses applications and issues production, distribution and marketing authorisations for veterinary medicines. The VMPU issues a recommendation to the Ministry of LNV via the Veterinary Medicines Board (CRD). In the Netherlands the Minister of LNV is responsible for the marketing authorisation of veterinary medicines. VMPU is also tasked with monitoring the adverse events of veterinary medicines, granting trial exemptions for veterinary medicines and feed additives and issuing batch approvals for veterinary vaccines, export certificates and authorisations for wholesale and retail trade.

The Dutch representatives on the Committee for Medicinal Products for Veterinary Use (CVMP) and in the CMDv (Coordination Group for Mutual Recognition and Decentralised Procedures (veterinary)) work within the VMPU. The number of procedures has remained stable throughout the years.

Assigned Centralised CVMP rapporteurships
201620172018
Number of rapporteurships624
Source: EMA Source table as .csv (50 bytes)
Assigned Centralised MRL rapporteurships
201620172018
Number of rapporteurships022
Source: EMA Source table as .csv (50 bytes)
Procedures concluded via the decentralised procedure, with share VMPU and RMS
LandAantal
Ireland50
United Kingdom43
France20
Spain16
The Netherlands15
Germany9
Czech Republic7
Hungary3
Belgium2
Estonia2
Denmark1
Italy1
Austria1
Source: EMA Source table as .csv (231 bytes)
Registered marketing authorisations
201620172018
Number of registered marketing authorisations229522722294
Source: MEB Source table as .csv (79 bytes)
Concluded cases, including variations
201620172018
Aantal575857646216
Source: MEB Source table as .csv (40 bytes)